Across TCGA pan-cancer cohorts, MTCP1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MTCP1 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MTCP1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTCP1 expression acts as an unfavorable survival marker.

COAD and SCLC are the cancer types where MTCP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.092	0.785	<.001	48	view →
SCLC	DFS	Median	All	0.192	0.793	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MTCP1 tumor-vs-normal RNA expression · all MTCP1 data types